Skip to main content
main-content

Bone diseases

Clinical trials

17-05-2018 | Osteoporosis | Article

Anti-osteoporosis drug use: Too little, too much, or just right? The HUNT study, Norway

Hoff M et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4560-3

02-05-2018 | Osteoporosis | Review | Article

Novel imaging modalities in osteoporosis diagnosis and risk stratification

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

30-04-2018 | Osteoarthritis | Article

Effects of glucosamine in patients with osteoarthritis of the knee: A systematic review and meta-analysis

Ogata T et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4106-2

30-04-2018 | Osteoporosis | Review | Article

Is calcifediol better than cholecalciferol for vitamin D supplementation?

Quesada-Gomez JM, Bouillon R. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-018-4520-y

18-01-2016 | Osteoporosis | Article

Efficacy of osteoporosis pharmacotherapies in preventing fracture among oral glucocorticoid users: a network meta-analysis

The authors assessed the efficacy of approved osteoporosis pharmacotherapies in preventing fracture and determined that teriparatide, risedronate, and etidronate led to a decreased vertebral fracture risk.

Amiche MA et al. Osteoporos Int 2016;27:1989–1998. doi:10.1007/s00198-015-3476-4